Covidien to Build Medical Device R&D Center in Shanghai

Covidien will build a medical device R&D center in Shanghai’s Caohejing Hi-Tech Park that will be operational by July 2012. The company’s R&D staff in China will jump from 25 at present to over 300 when the 100,000 square foot facility is finished. Covidian, which is headquartered in Dublin, but has most of its managing operations in the US, is comprised of three life science divisions: medical devices, pharmaceuticals and medical products. More details.... Stock Symbol: (NYSE: COV)